Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 5Prostatic Neoplasms 3Desmoid Tumors 3Melanoma 2Lung Neoplasms 2Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Solid Tumor, Adult 1Skin Neoplasms 1Sarcoma 1Pancreatic Adenocarcinoma Locally Advanced 1Neuroma 1Neuralgia 1Neoplasm Metastasis 1Liver Neoplasms 1Liver Metastasis 1Hypesthesia 1Disease 1Colorectal Neoplasms 1Cirrhosis, Familial, with Pulmonary Hypertension 1Cholangiocarcinoma 1Carcinoma, Transitional Cell 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Agnosia 1Adenocarcinoma of Lung 1

Interventions

pembrolizumab 8Nivolumab 6Ipilimumab 6cemiplimab 4aldesleukin 3Interleukin-2 3fludarabine 2Specimen Handling 2Niacinamide 2HhAntag691 2Cyclophosphamide 2Blood Specimen Collection 2Biopsy 2trametinib 1spartalizumab 1sonidegib 1pertuzumab 1lifileucel 1four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate) 1fludarabine phosphate 1dabrafenib 1brodalumab 1atezolizumab 1Vitamin A 1Trastuzumab 1Tissue Banks 1Surgical Procedures, Operative 1Sunscreening Agents 1Standard of Care 1Second Harmonic Generation Microscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Skin Neoplasms × Cryosurgery × Clear all
NCT05779423 2026-05-19

Cryoablation+Ipilimumab+Nivolumab in Melanoma

Massachusetts General Hospital

Phase 2 Recruiting
37 enrolled
Dermatologic

Melanoma, Skin Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡